Skip to main content

Controversial Issues Surrounding Direct-to-Consumer Advertisements of Prescription Drugs

  • Conference paper
  • First Online:
Proceedings of the 1993 Academy of Marketing Science (AMS) Annual Conference

Abstract

Issues concerning the use of direct-to-consumer (DTC) advertisements of prescription drugs are explored. In addition, the background of the pharmaceutical industry as well as the history of DTC advertisements of prescription drugs are detailed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adweek’s Marketing Week 1988. “Drug Companies Go Directly to Consumers in Quest for Doctors’ Prescriptions,” 29 (January 4), 21.

    Google Scholar 

  • American Druggist (1988), “APHA Endorses Manufacturers’ Direct-to-Consumer Rx Drug Ads,” 197 (May) 26, 28.

    Google Scholar 

  • Banerjee, Sumanta 1983. “Use and Misuse of the Media,” World Healthy (February/March), 18–20. Business Week (1984) “Going to the Public With Ads for Prescription Drugs,” (May 21), 77, 81.

    Google Scholar 

  • Cohen, Eric P. 1988. “Sounding Board, Direct-to- the-Public Advertisement of Prescription Drugs,” New England Journal of Medicine, 318 (February 110, 373–376.

    Article  Google Scholar 

  • Colford, Steven W. 1985a. “New Rx for Drug Ads,” Advertising Age, 56 (August 26), 1, 54.

    Google Scholar 

  • — 1985b. “CBS Readies for Prescription-Drug Ads,” Advertising Age, 56 (November 11), 12, 90.

    Google Scholar 

  • — and Richard L. Gordon 1987. “CBS Opens Study, FDA Nixes Drug Ad Review,” Advertising Age, 58 (December 21), 33.

    Google Scholar 

  • — and Joe Mandese 1991. “FDA Calls Retreat on Drug Ad Guides,” Advertising Age, 63 (February 3), 1, 41.

    Google Scholar 

  • Consumer Reports 1984. “Should Prescription Drugs Be Advertised to Consumers?,” 66 (July), 392–393.

    Google Scholar 

  • DeBenedette, Valerie 1986. “Penicillin-The Commercial,” Health, 18 (April), 57–59.

    Google Scholar 

  • Deutsch, Claudia H. 1989. “The Brouhaha Over Drug Ads,” The New York Times, 138 (May 14), IF, 8F.

    Google Scholar 

  • Donaton, Scott 1992. “Nicotine Patch Eases Cig Ad Retreat,” Advertising Age, 63 (June 29), 12.

    Google Scholar 

  • Edmondson, Brad 1987. “Merrell Dow Talks to People,” American Demographics, 9 (January), 22–323.

    Google Scholar 

  • Gladwell, Malcolm and Paul Farhi 1990. “Drug Firms Offering New Prescription for TV Ads,” Washington Post, 113 (January 28), HI, H4.

    Google Scholar 

  • Hiestand, Michael 1988. “Research Says Consumers Favor Ads for Rx Drugs,” Adweeks Marketing Week, 29 (May 23), 4.

    Google Scholar 

  • Hoff, Lawrence C. 1984. “Advertising Prescription Drugs Direct to the Public,” Vital Speeches of the Day, 50 (July 1), 573–576.

    Google Scholar 

  • Levine, Joanne 1987. “Pharmaceuticals: Medical Marketing (Part 2),” Incentive Marketing, 8 (August), 54–58, 93.

    Google Scholar 

  • Masson, Alison and Paul H. Rubin 1986. “Plugs for Drugs,” Regulation, (September/October), 37–43, 53.

    Google Scholar 

  • Miles, Christine E. 1984. “They–d Rather Switch,” Forbes, 133 (March 12), 162.

    Google Scholar 

  • Miller, Annetta, Todd Barrett and Elizabeth Bradburn 1989. “Pitching to Patients,” Newsweek, 106 (May 8), 40–41.

    Google Scholar 

  • Neumann, Karl 1988. “Rx Drugs and the Information Explosion,” American Druggist, 197 (March), 50.

    Google Scholar 

  • Rogers, Alison 1986. “Prescription Drug Ads Still Cloudy,” Adweek, 27 (April 28), 18.

    Google Scholar 

  • Sheffet, Mary Jane and Steven W. Kopp 1990. “Advertising Prescription Drugs to the Public: Headache or Relief?,” Journal of Public Policy and Marketing, 9, 42–61.

    Google Scholar 

  • Shugar, Gerald R. 1986. “Mixed Opinions on Direct- to-Consumer Advertising,” Medical Marketing and Media, 21 (August), 36–41.

    Google Scholar 

  • Spalding, F.J. 1986. “Generic vs. Brandname Drugs: A Bare-Knuckles Fight,” Chemical Week, 138 (February 19), 28–32.

    Google Scholar 

  • Stern, Aimee L. 1987. “Drug Makers Learn the Hard Sell,” Business Month, 130 (November), 18.

    Google Scholar 

  • Television/Radio Age 1987. “New Prescription for Drug Spots,” 34 (April 13), 63–65.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 The Academy of Marketing Science

About this paper

Cite this paper

Schrader, J.T. (2015). Controversial Issues Surrounding Direct-to-Consumer Advertisements of Prescription Drugs. In: Levy, M., Grewal, D. (eds) Proceedings of the 1993 Academy of Marketing Science (AMS) Annual Conference. Developments in Marketing Science: Proceedings of the Academy of Marketing Science. Springer, Cham. https://doi.org/10.1007/978-3-319-13159-7_123

Download citation

Publish with us

Policies and ethics